Mixed connective tissue disease — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Mixed connective tissue disease
The diagnosis is mixed connective tissue disease. The discriminating combination is strongly positive, high-titre anti-U1 RNP antibodies with Raynaud phenomenon, puffy hands, inflammatory synovitis and oesophageal dysmotility. These represent overlapping connective-tissue-disease manifestations typical of MCTD. Limited systemic sclerosis can cause Raynaud phenomenon and oesophageal dysmotility, but the absence of skin thickening and the anti-U1 RNP-dominant inflammatory phenotype favour MCTD. Anti-U1 RNP antibodies may occur in SLE, but the stem lacks characteristic SLE manifestations or SLE-specific serology. Rheumatoid arthritis does not explain the Raynaud–puffy-hand–oesophageal phenotype. Undifferentiated connective tissue disease is less appropriate because the clinical and serological pattern supports a recognised MCTD phenotype. Pulmonary arterial hypertension and interstitial lung disease are important subsequent complications.
Reference: Ferrara CA et al. Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives. ImmunoTargets and Therapy. 2023;12:79–89. https://pubmed.ncbi.nlm.nih.gov/37525698/